Clinical Trials
37 trialsSTAR-221
Arcus Biosciences, Inc.
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
AstraZeneca
HERIZON-GEA-01
Jazz Pharmaceuticals
Spotlight
Astellas Pharma Inc
KEYNOTE-585
Merck Sharp & Dohme LLC
KEYNOTE-585
Merck Sharp & Dohme LLC
KEYNOTE-859
Merck Sharp & Dohme LLC
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
Suzhou Transcenta Therapeutics Co., Ltd.
MK-3475-811
Merck Sharp & Dohme LLC
CheckMate649
Bristol-Myers Squibb
Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Fujian Cancer Hospital
FLOT5
Krankenhaus Nordwest
PREVENT
Krankenhaus Nordwest
DIGEST
Taiho Oncology, Inc.
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Chinese University of Hong Kong
MK-3475-062
Merck Sharp & Dohme LLC
KEYNOTE-859
Merck Sharp & Dohme LLC
Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma
Fudan University
Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
UNICANCER
JACOB
Hoffmann-La Roche
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Seoul National University Hospital
Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
Jonsson Comprehensive Cancer Center
GAMMA-1
Gilead Sciences
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Alliance for Clinical Trials in Oncology
Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial
National Institutes of Health Clinical Center (CC)
Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis
Nanfang Hospital, Southern Medical University
A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer
Hoffmann-La Roche
GASTRANOX
Thrombosis Research Institute
ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer
Hoffmann-La Roche
XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)
Dong-A University Hospital
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
National Cancer Institute (NCI)
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
Trans Tasman Radiation Oncology Group
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Taxotere New Indication - Gastric Cancer Treatment Registration Trial
Sanofi
Trial of S-1 Plus Cisplatin in Gastric Cancer
Sun Yat-sen University
Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Taiho Pharmaceutical Co., Ltd.